In conclusion, our study showed an association of TIM-3 and LGALS9 polymorphisms with ccRCC risk and outcomes; however, extended studies on larger groups of patients and the functional evaluation of studied SNPs are needed to confirm our results. The gene discussed is LGALS9; the disease is nonpapillary renal cell carcinoma.